Lenvakast 4

Lenvatinib Capsules 4 mg

Send Enquiry

Medicine*

Your Name*

Your Email*

Your Phone*

Your Country*

Message

Categories: Oncology, Oncology Orals Manufacturer

Description
Download Product PDF Attachment

Description

COMPOSITION: Each capsule contains Lenvatinib 4 mg.

INDICATION:

LENVAKAST is indicated for The treatment of patients with locally recurrent or metastatic, progressive, radioactive iodine-refractory diflerentiated thyroid cancer (DTc).
LENVAKAST is indicated for the first-line treatment of patients with unresectable hepatocellular carcinoma.
LENVAKAST is also indicated for Endometrial carcinom.

PACKING: 3×10 capsules / Strip

Download Product PDF Attachment

Disclaimer: This medical information is intended only for healthcare professionals in India. The products discussed herein may have different product labeling in other countries. The information within this site is intended to provide balanced, scientific, and evidence-based answers to unsolicited medical questions. For full Prescribing Information including indications, contraindications, warnings, precautions, and adverse events, please submit a medical information request. This information is not intended as medical advice. Responsibility for patient care resides with the healthcare professional on the basis of his or her professional license, experience and knowledge of the patient. Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement. Any liability for patent infringement is at the buyer's risk. The website does not sell/purchase any medicine.

This website uses cookies to help us give you the best experience when you visit. By using this website you consent to our Terms of Use. For more information please click here. Accept

Lenvakast 4

Thank you for your enquiry. We will get back to you shortly!

Description

Related products